Suppliers and packages for generic ingredient: EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
✉ Email this page to a colleague
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | TRIJARDY XR | empagliflozin; linagliptin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212614 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0380-13 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-13) | 2020-04-23 |
| Boehringer Ingelheim | TRIJARDY XR | empagliflozin; linagliptin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212614 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0380-22 | 1 BOTTLE in 1 CARTON (0597-0380-22) / 7 TABLET, EXTENDED RELEASE in 1 BOTTLE | 2020-04-23 |
| Boehringer Ingelheim | TRIJARDY XR | empagliflozin; linagliptin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212614 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0380-68 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-68) | 2020-04-23 |
| Boehringer Ingelheim | TRIJARDY XR | empagliflozin; linagliptin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212614 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0385-77 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-77) | 2020-04-23 |
| Boehringer Ingelheim | TRIJARDY XR | empagliflozin; linagliptin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212614 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0385-86 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86) | 2020-04-23 |
| Boehringer Ingelheim | TRIJARDY XR | empagliflozin; linagliptin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212614 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0385-88 | 1 BOTTLE in 1 CARTON (0597-0385-88) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE | 2020-04-23 |
| Boehringer Ingelheim | TRIJARDY XR | empagliflozin; linagliptin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212614 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0390-13 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13) | 2020-04-23 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
